Trial intelligence / Profile preview

Efficacy and Safety of Anaprazole in Duodenal Ulcers

NCT04503629Phase 2Completed

Sponsor
Sihuan Pharmaceutical
Start
Oct 2018
Primary completion
May 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Anaprazole in duodenal ulcer, sponsored by Sihuan Pharmaceutical. Started Oct 2018; status: completed.

02

Drugs

Anaprazole
03

Conditions

duodenal ulcer

Beyond the preview

Go deeper on NCT04503629.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04503629.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call